Organoid Center Strategies

Rupendra Shrestha December 15, 2018

Focus Area

  1. Organoid Science
  2. Organoid Prototyping
  3. Organoid Translation
  4. Organoid Commercialization

Reference Link: Takanori T., James M., Michael A. H., and Aaron M. Z. 2018. Cell Stem Cell

Representative Illustration: Major Acceleration Targets for Organoid Medicine Realization

More Stories

The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

Rupendra Shrestha October 30, 2024

Six3 and Six6 jointly control diverse target genes in multiple cell populations over developmental trajectories of mouse embryonic retinal progenitor cells

Rupendra Shrestha October 24, 2024

Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

Rupendra Shrestha August 25, 2024

You may have missed

The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

Rupendra Shrestha October 30, 2024

Six3 and Six6 jointly control diverse target genes in multiple cell populations over developmental trajectories of mouse embryonic retinal progenitor cells

Rupendra Shrestha October 24, 2024

Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

Rupendra Shrestha August 25, 2024

Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

Rupendra Shrestha June 5, 2024

Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights

Rupendra Shrestha April 25, 2024